Zhenfan Yang
Impact in
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Lung Cancer Diagnosis and Treatment
- Oncology top 5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 21
- Brain Metastases and Treatment 7
- Oncology 13
- Lung Cancer Research Studies 8
- Co-authors
- James Chih‐Hsin Yang (10 shared papers)Dong‐Wan Kim (7 shared papers)Irene Oi‐Lin Ng (1 shared paper)Wun‐Ching Yu (1 shared paper)John Wong (1 shared paper)Cecilia Lau (1 shared paper)Ronnie Tung‐Ping Poon (1 shared paper)Pasi A. Jänne (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Journal of Thoracic Oncology (3 papers)Blood (2 papers)Lung Cancer (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- ChinaSouth KoreaTaiwan
In The Last Decade
Zhenfan Yang
39 papers receiving 1.8k citations
Zhenfan Yang's Hit Papers
Peers
Comparison fields: 5 of 82
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 767
- Hepatology 116
- Cancer Research 206
- Genetics 103
Countries citing papers authored by Zhenfan Yang
This map shows the geographic impact of Zhenfan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenfan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenfan Yang more than expected).
Fields of papers citing papers by Zhenfan Yang
This network shows the impact of papers produced by Zhenfan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenfan Yang. The network helps show where Zhenfan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenfan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity Hit paper breakdown → | 2016 | 534 |
| 2 | 2002 | 241 | |
| 3 | 2017 | 97 | |
| 4 | 2017 | 87 | |
| 5 | 2016 | 80 | |
| 6 | 2016 | 78 | |
| 7 | 2017 | 74 | |
| 8 | 2013 | 66 | |
| 9 | 2018 | 59 | |
| 10 | 2002 | 54 | |
| 11 | 2017 | 45 | |
| 12 | 2016 | 44 | |
| 13 | 2004 | 40 | |
| 14 | 2016 | 37 | |
| 15 | 2004 | 33 | |
| 16 | 2018 | 32 | |
| 17 | 2018 | 30 | |
| 18 | 2015 | 28 | |
| 19 | 2022 | 21 | |
| 20 | 2000 | 20 |
About Zhenfan Yang
Zhenfan Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 39 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (8 papers), Brain Metastases and Treatment (7 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Auction Theory and Applications (2 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Oncology (767 citations), Hepatology (116 citations), Cancer Research (206 citations) and Genetics (103 citations). Zhenfan Yang has collaborated with scholars based in China, South Korea and Taiwan. Frequent co-authors include James Chih‐Hsin Yang, Dong‐Wan Kim, Irene Oi‐Lin Ng, Wun‐Ching Yu, John Wong, Cecilia Lau, Ronnie Tung‐Ping Poon, Pasi A. Jänne, Darren A.E. Cross and Peter Ballard. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Blood, Lung Cancer and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.